Avid Bioservices Inc (CDMO)

[jazzbeerman]

jake,

If you can find any Avastin or Erbitux data after only about 8 weeks of therapy let me know. I doubt you'll find any.

This is such a short time of therapy to announce results, especially results like this, I'm stunned.

Also - I don't think Avastin or Erbitux see a 45% (5 out of 11) objective response rate.

This is early, but very promising news.

The most important thing to me is that, unlike Erbitix or Avastin, which only potentially work on a certain subset of people with certain tumor types, Bavi should work on ANY AND ALL of 'em, due to HOW it works.

AND IT SHOULD KEEP WORKING.

IMO, We'll be seeing that "OBJECTIVE RESPONSE" percentage CLIMBING in the coming weeks.

We'll be seeing even BETTER headlines, SHORTLY, IMO, on the patients' next scans, based on Bavituximab's MOA's.



j